[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-343116-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-343116-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-pathogenic-role-of-retinoid-nuclear-receptor-signaling-in-cancer-and-metabolic-syndromes-review","The pathogenic role of retinoid nuclear receptor signaling in cancer and metabolic syndromes - review","","Retinoid nuclear receptor signaling, driven by retinoic acid derived from dietary vitamin A, has been studied for over a century and yields conflicting views on its regulation and therapeutic manipulation. Retinoid agonists benefit select rare bone disorders, acute promyelocytic leukemia, and some dermatologic diseases, yet often cause acute metabolic dysregulation and delayed cancer-promoting effects. This review synthesizes clinical, mechanistic, and genetic evidence to argue that inhibiting retinoid pathway activity may be compelling for certain solid cancers and metabolic syndromes, while cautioning against continued retinoid agonist testing in cancer patients. Findings also highlight retinoid roles in immunity and metabolism and propose antagonizing retinoid signaling in diabetes and obesity.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-pathogenic-role-of-retinoid-nuclear-receptor-signaling-in-cancer-and-metabolic-syndromes-review/343116/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-pathogenic-role-of-retinoid-nuclear-receptor-signaling-in-cancer-and-metabolic-syndromes-review/343116.png","ImageObject",300,407,{"name":42,"@type":43},"Asher","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why does retinoid nuclear receptor signaling show conflicting therapeutic hypotheses?","Question",{"text":63,"@type":64},"Retinoid agonists can help specific rare conditions, but they also frequently trigger acute metabolic dysregulation and later cancer-promoting effects, creating a core contradiction in expected outcomes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What activates conventional nuclear retinoid signaling?",{"text":68,"@type":64},"All-trans retinoic acid (atRA) binds retinoic acid nuclear receptors (RARs), producing transcriptional changes that influence development, immune tolerance/trafficking, spermatogenesis, and metabolic pathways.",{"name":70,"@type":61,"acceptedAnswer":71},"Which therapeutic strategy does the review suggest for cancers and metabolic syndromes?",{"text":72,"@type":64},"The review discusses evidence supporting inhibition of the retinoid pathway as a compelling approach in certain solid cancers and metabolic syndromes, while advising caution about continued testing of retinoid agonists in cancer patients.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},343116,1790259541,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","REVIEW  \nCancer Focus  \nThe pathogenic role of retinoid nuclear receptor signaling in cancer and metabolic syndromes  \nMark Esposito1,2􀀁, John K. Amory3􀀁, and Yibin Kang1,4􀀁  \nThe retinoid nuclear receptor pathway, activated by the vitamin A metabolite retinoic acid, has been extensively investigated for over a century. This study has resulted in conflicting hypotheses about how the pathway regulates health and how it should be pharmaceutically manipulated. These disagreements arise from a fundamental contradiction: retinoid agonists offer clear benefits to select patients with rare bone growth disorders, acute promyelocytic leukemia, and some dermatologic diseases, yet therapeutic retinoid pathway activation frequently causes more harm than good, both through acute metabolic dysregulation and a delayed cancer-promoting effect. In this review, we discuss controlled clinical, mechanistic, and genetic data to suggest several disease settings where inhibition of the retinoid pathway may be a compelling therapeutic strategy, such as solid cancers or metabolic syndromes, and also caution against continued testing of retinoid agonists in cancer patients. Considerable evidence suggests a central role for retinoid regulation of immunity and metabolism, with therapeutic opportunities to antagonize retinoid signaling proposed in cancer, diabetes, and obesity.  \nIntroduction  \nThe retinoid pathway is complex. Conventional nuclear retinoid signaling is activated when all-trans retinoic acid (atRA), an oxidized metabolite of dietary vitamin A, binds the retinoic acid nuclear receptors (RARs). This binding results in changes in transcription, including morphogenic activity in development, regulation of immune tolerance and trafficking, spermatogenesis, as well as control of metabolic pathways (Altucci et al., 2007; Duester, 2008; Hall et al., 2011b) . In addition to the conventional branch of retinoid signaling that activates the RAR nuclear receptors, the vitamin A pathway diverges into three other branches that are governed by stereoisomerization at the 9, 11, and 13 positions of retinol: the visual cycle in the eye enabled by 11-cis retinaldehyde, non-nuclear regulation by 13-cis retinoids, and rexinoid signaling activated by 9-cis retinoic acid (Fig. 1) .  \nThere is considerable complexity in the nuclear signaling pathway as the RAR/rexinoid X receptor (RXR) nuclear receptors participate in gene regulation in both the apo-and retinoic acid–bound states (Germain et al., 2002) . These receptors are characterized by complex splicing regulation at the N-terminus that can result in context-dependent signaling, and both RAR and RXR receptors participate in non-retinoid nuclear receptor heterodimer signaling (Rochette-Egly and Germain, 2009) . The combination of this biological complexity with unique technical hurdles, such as photoinstability of retinoid stereoisomers, low  \nnanomolar concentrations in tissues, and lipophilicity of theretinoids, have all combined to make this pathway a difficult topic for study (Kane et al., 2005) .  \nDespite this complexity, the retinoid pathway was one of the first discovered biological pathways; nutritional deprivation studies in the 1800s described effects later traced to retinol deficiency, and retinol was definitively isolated in 1918 as vitamin A (Semba, 2012) . Since this discovery, the metabolic cascade from retinol intake to elimination has been well-described (Fig. 1) . Whereas vitamin A is a precursor to four divergent pathways, synthetic retinoids that specifically activate each signaling branch were subsequently generated and have been used both in research and clinical treatment settings. Key advances from these efforts include approved RAR agonists for acute promyelocytic leukemia (tretinoin; synthetic atRA) and fibrodysplasia ossificans progressiva (palovarotene, RARγ agonist), 13-cis retinoic acid (isotretinoin/Accutane), and adapalene for dermatological applications to activate the non-nucl","cbCaimUo12RuOOXA","https://ap.wps.com/l/cbCaimUo12RuOOXA","pdf",2292192,22,"English","# Introduction\n## Retinoid nuclear signaling complexity and pathway branches\n## Biological rationale, historical discovery, and therapeutic advances","[{\"question\":\"Why does retinoid nuclear receptor signaling show conflicting therapeutic hypotheses?\",\"answer\":\"Retinoid agonists can help specific rare conditions, but they also frequently trigger acute metabolic dysregulation and later cancer-promoting effects, creating a core contradiction in expected outcomes.\"},{\"question\":\"What activates conventional nuclear retinoid signaling?\",\"answer\":\"All-trans retinoic acid (atRA) binds retinoic acid nuclear receptors (RARs), producing transcriptional changes that influence development, immune tolerance/trafficking, spermatogenesis, and metabolic pathways.\"},{\"question\":\"Which therapeutic strategy does the review suggest for cancers and metabolic syndromes?\",\"answer\":\"The review discusses evidence supporting inhibition of the retinoid pathway as a compelling approach in certain solid cancers and metabolic syndromes, while advising caution about continued testing of retinoid agonists in cancer patients.\"}]","The pathogenic role of retinoid nuclear receptor signaling in cancer and metabolic syndromes - review | PDF",1790049961,55,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ea6919262a9b16dd05ea8e8a36b557b4.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/20dc4ab5f06760ebb24c8419e322c1d6.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/009c4f2c586fc597d9cdee92cf210a1a.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c0487bb85a19d4e3315938af49db7f58.webp",980,1268]